EP2191831
Breyting á piriferidón-meðferð fyrir sjúklinga með afbrigðilega lifrarstarfsemi.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
6.11.2009EP published:
30.3.2011EP application number:
09252572.4
EP translation filed:
20.4.2011Grant published:
15.5.2011EPO information:
European Patent Register
Max expiry date:
5.11.2029Expiry date:
5.11.2018
Title:
Modifying pirfenidone treatment for patients with atypical liver function
Timeline
Today
6.11.2009EP application
30.3.2011EP Publication
20.4.2011Translation submitted
15.5.2011Registration published
5.11.2018Expires
Owner
Name:
Intermune, Inc.Address:
c/o Genentech, Inc., Legal Department, 1 DNA Way, 94080-4990, South San Francisco, CA, US
Inventor
Name:
Bradford, Williamson ZieglerAddress:
Wilson, WY, US
Name:
Szwarcberg, JavierAddress:
San MateoCalifornia, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
113107 PDate:
10.11.2008Country:
US
Number:
228943 PDate:
27.7.2009Country:
US
Number:
553292Date:
3.9.2009Country:
US
Number:
428393Date:
22.4.2009Country:
US
Classification
Categories:
A61K 31/4412, A61P 11/00
Annual fees
Number
Paid
Expires
Payer
Number: 3
Paid: 27.10.2011
Expires: 5.11.2012
Payer: Sigurjónsson & Thor ehf.
Number: 4
Paid: 5.10.2012
Expires: 5.11.2013
Payer: Sigurjónsson & Thor ehf.
Number: 5
Paid: 9.10.2013
Expires: 5.11.2014
Payer: Árnason Faktor
Number: 6
Paid: 24.10.2014
Expires: 5.11.2015
Payer: Árnason Faktor
Number: 7
Paid: 26.10.2015
Expires: 5.11.2016
Payer: Árnason Faktor
Number: 8
Paid: 13.10.2016
Expires: 5.11.2017
Payer: Árnason Faktor
Number: 9
Paid: 5.10.2017
Expires: 5.11.2018
Payer: Árnason Faktor